Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1991-3-27
pubmed:abstractText
The poliovirus P2/P712 strain is an attenuated virus that is closely related to the type 2 Sabin vaccine strain. By using a mouse model for poliomyelitis, sequences responsible for attenuation of the P2/P712 strain were previously mapped to the 5' noncoding region of the genome and a central region encoding VP1, 2Apro, 2B, and part of 2C. To identify specific determinants that attenuate the P2/P712 strain, recombinants between this virus and the mouse-adapted P2/Lansing were constructed and their neurovirulence in mice was determined. By using this approach, the attenuation determinant in the central region was mapped to capsid protein VP1. Candidate attenuating sequences in VP1 and the 5' noncoding region were identified by comparing the P2/P712 sequence with that of vaccine-associated isolate P2/P117, and the P2/117 sequences were introduced into the P2/Lansing-P2/P712 recombinants by site-directed mutagenesis. Results of neurovirulence assays in mice indicate that an A at nucleotide 481 in the 5' noncoding region and isoleucine (Ile) at position 143 of capsid protein VP1 are the major determinants of attenuation of P2/P712. These determinants also attenuated neurovirulence in transgenic mice expressing human poliovirus receptors, a new model for poliomyelitis in which virulent viruses are not host restricted. These results demonstrate that A-481 and Ile-143 are general determinants of attenuation.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1847458-2169383, http://linkedlifedata.com/resource/pubmed/commentcorrection/1847458-2170026, http://linkedlifedata.com/resource/pubmed/commentcorrection/1847458-2471354, http://linkedlifedata.com/resource/pubmed/commentcorrection/1847458-2539491, http://linkedlifedata.com/resource/pubmed/commentcorrection/1847458-2548847, http://linkedlifedata.com/resource/pubmed/commentcorrection/1847458-2552175, http://linkedlifedata.com/resource/pubmed/commentcorrection/1847458-2825415, http://linkedlifedata.com/resource/pubmed/commentcorrection/1847458-2825586, http://linkedlifedata.com/resource/pubmed/commentcorrection/1847458-2836553, http://linkedlifedata.com/resource/pubmed/commentcorrection/1847458-2838906, http://linkedlifedata.com/resource/pubmed/commentcorrection/1847458-2843017, http://linkedlifedata.com/resource/pubmed/commentcorrection/1847458-2849960, http://linkedlifedata.com/resource/pubmed/commentcorrection/1847458-2983090, http://linkedlifedata.com/resource/pubmed/commentcorrection/1847458-2994218, http://linkedlifedata.com/resource/pubmed/commentcorrection/1847458-3003384, http://linkedlifedata.com/resource/pubmed/commentcorrection/1847458-3039178, http://linkedlifedata.com/resource/pubmed/commentcorrection/1847458-6085198, http://linkedlifedata.com/resource/pubmed/commentcorrection/1847458-6093054, http://linkedlifedata.com/resource/pubmed/commentcorrection/1847458-6202874, http://linkedlifedata.com/resource/pubmed/commentcorrection/1847458-6272391
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0022-538X
pubmed:author
pubmed:issnType
Print
pubmed:volume
65
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1377-82
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1991
pubmed:articleTitle
Identification of two determinants that attenuate vaccine-related type 2 poliovirus.
pubmed:affiliation
Department of Microbiology, College of Physicians & Surgeons, Columbia University, New York, New York 10032.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't